Setting Cancer Cells on the Right Path: A New Leukemia Drug Shows Growing Promise

Add a Comment By Eva Kiesler, PhD, Science Writer/Editor   |  Friday, January 30, 2015 An experimental drug for acute myelogenous leukemia might potentially help many more patients than previously thought by controlling epigenetic processes, according to a recent MSK study. read more

[read_more text="For More........" title="For More........" url="https://thinkpinkrocks.org/setting-cancer-cells-on-the-right-path-a-new-leukemia-drug-shows-growing-promise/" align="left"]
[divider_top]

MSK Plays Critical Role in FDA Approval of New Melanoma Drug

Add a Comment By Jim Stallard, MA, Writer/Editor   |  Tuesday, January 6, 2015 A new treatment for advanced melanoma is the latest promising advance in immunotherapy tested in large part by our scientists.

[read_more text="For More........" title="For More........" url="https://thinkpinkrocks.org/msk-plays-critical-role-in-fda-approval-of-new-melanoma-drug/" align="left"]
[divider_top]

Five Fascinating Approaches to Cancer Science

Add a Comment By Christina Pernambuco-Holsten, MA, Managing Web Editor   |  Tuesday, December 30, 2014 From tropical plants and 3-D snapshots of worms to tiny particles that light up tumors, here’s a glimpse at some of the fascinating work MSK researchers pursued in 2014 as part of our quest to advance cancer science.

[read_more text="For More........" title="For More........" url="https://thinkpinkrocks.org/five-fascinating-approaches-to-cancer-science/" align="left"]
[divider_top]

Can Cells Be Turned from Cancerous to Normal?

2 comments By Julie Grisham, MS, Science Writer/Editor   |  Thursday, December 11, 2014 An experimental drug for blood cancers with certain genetic mutations is showing promise in early-stage trials.

[read_more text="For More........" title="For More........" url="https://thinkpinkrocks.org/can-cells-be-turned-from-cancerous-to-normal/" align="left"]
[divider_top]

Disorderly DNA: Researchers Simulate a Common Cause of Lung Cancer

1 comment By Eva Kiesler, PhD, Science Writer/Editor   |  Thursday, November 6, 2014 For the first time, Memorial Sloan Kettering scientists have created a mouse model that replicates a subtype of non-small cell lung cancer caused by a chromosomal rearrangement — a type of mutation that is common in cancers but thus far has been very difficult to study. read more

[read_more text="For More........" title="For More........" url="https://thinkpinkrocks.org/disorderly-dna-researchers-simulate-a-common-cause-of-lung-cancer/" align="left"]
[divider_top]

Clearing Up Clinical Trials: Myths and Misconceptions

Add a Comment By Esther Napolitano, BS, Science Writer/Editor   |  Monday, October 20, 2014 Medical oncologist Paul Sabbatini demystifies common misconceptions surrounding clinical trials. read more

[read_more text="For More........" title="For More........" url="https://thinkpinkrocks.org/clearing-up-clinical-trials-myths-and-misconceptions/" align="left"]
[divider_top]

The Enemy’s Telltale Mark: Researchers Find Novel Way Body Defends against Harmful Bacteria

Add a Comment By Jim Stallard, MA, Writer/Editor   |  Tuesday, October 21, 2014 MSK researchers discover that the body senses and attacks harmful bacteria indirectly after the pathogens cause stress within the cells. read more

[read_more text="For More........" title="For More........" url="https://thinkpinkrocks.org/the-enemys-telltale-mark-researchers-find-novel-way-body-defends-against-harmful-bacteria/" align="left"]
[divider_top]